INS and Insulin resistance: The results showed an improvement in insulin resistance and an increase in the secretion of insulin (40%) in INS-1 cells, a reduction in glucose levels in obese mice (20%), as well as a decreased in body weight (25%) the supplemented obese mice between baseline and day 30 of treatment.